Research findings have indicated that miR-124 exhibits significant pathogenic involvement in PD progression.[197] Genetic knockdown of CDK5 demonstrates therapeutic potential by upregulating BDNF expression and ameliorating synaptic impairments in PD models. Here, BDNF is linked to Parkinson disease.